Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations (2025)
Chapter: Appendix B: Open Session Meeting Agendas
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix A: Committee Member and Staff Biosketches
B
Next Chapter: Appendix C: Public Law 116-171
Suggested Citation:
"Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press.
doi: 10.17226/28584.
B
Open Session Meeting Agendas
COMMITTEE ON THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES ON ALL-CAUSE MORTALITY IN VETERANS
February 3, 2023
| 1:00–1:05pm | Welcome and Introductions; Conduct of the Open Session Brian Strom, Committee Chair |
| 1:05–2:00 | Charge to the Committee and Background on Section 204a Hannon Act David Atkins, VA Research Health Services Research and Development |
| Jodie Trafton, Program Evaluation and Resource Center for the VHA Office of Mental Health and Suicide Prevention | |
| Friedhelm Sandbrink, Pain Management, Opioid Safety and Prescription Drug Monitoring Programs (PMOP), Specialty Care Program Office, Veterans Health Administration | |
| 2:00–2:30 | Overview of Available Data Sources Jodie Trafton, VHA Office of Mental Health and Suicide Prevention Friedhelm Sandbrink, Acting VHA National Program Director for Pain Management |
| 2:30–2:45 | Congressional Request Emily Blair Rubright, U.S. Senate Committee on Veterans’ Affairs |
| 2:45–3:00 | Public Comments |
| 3:00 | Open Session Ends |
Suggested Citation:
"Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press.
doi: 10.17226/28584.
March 9, 2023
| 9:00–9:05am | Welcome Brian Strom, Committee Chair |
| 9:05–10:05 | Panel: Trends in Opioid and Benzodiazepine Use, Addiction, and Related Overdose Secular Trends in Opioid and Benzodiazepine Use Christopher Jones, Centers for Disease Control and Prevention |
| Distinguishing Between Effect of Prescription Opioids Versus Synthetic/Illicit Opioids Sequela of Opioid Addiction, Comorbid Mental Health Conditions, and Suicide Risk William Becker, Yale School of Medicine | |
| 10:05-11:00 | Panel: Data and Design Considerations |
| 10:05–10:40 | Opioid Dose Reduction Trial Emulation Erin Krebs, Minneapolis VA Health Care System |
| 10:40–11:00 | Approaches to Examining Effects of Prescribed Opioid Use Corey Hayes, University Arkansas for Medical Sciences Bradley Martin, University Arkansas for Medical Sciences |
| 11:00–11:10 | Break |
| 11:10–11:30 | Data and Design: Associations Between Stopping Prescriptions and Overdose or Suicide Deaths in U.S. Veterans Elizabeth Oliva, Department of Veterans Affairs Jodie Trafton, Department of Veterans Affairs |
| 11:30–12:00 | Panel: Provider and Veteran Perspectives Patients’ and Providers’ Perspective on Tapering Joseph Frank, University of Colorado Perspectives from Veterans’ Service Organizations Alex Balbir, Wounded Warrior Project |
| 12:00 noon | Open Session Adjourns |
Suggested Citation:
"Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press.
doi: 10.17226/28584.
Suggested Citation:
"Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press.
doi: 10.17226/28584.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.